Overview
Gabexate is a synthetic serine protease inhibitor which has been used as an anticoagulant. It also known to decrease production of inflammatory cytokines. Gabexate has been investigated for use in cancer, ischemia-reperfusion injury, and pancreatitis.
Background
Gabexate is a synthetic serine protease inhibitor which has been used as an anticoagulant. It also known to decrease production of inflammatory cytokines. Gabexate has been investigated for use in cancer, ischemia-reperfusion injury, and pancreatitis.
Indication
No approved indication.
Associated Conditions
- Acute Pancreatitis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Gabexate Mesylate for Injection | 国药准字H20093269 | 化学药品 | 注射剂 | 8/23/2023 | |
| Gabexate Mesylate for Injection | 国药准字H20103254 | 化学药品 | 注射剂 | 4/17/2020 | |
| Gabexate Mesylate for Injection | 国药准字H20163097 | 化学药品 | 注射剂 | 12/1/2020 | |
| Gabexate Mesylate for Injection | 国药准字H20066577 | 化学药品 | 注射剂 | 7/21/2021 | |
| Gabexate Mesylate for Injection | 国药准字H20153228 | 化学药品 | 注射剂 | 10/22/2020 | |
| Gabexate Mesylate for Injection | 国药准字H20065698 | 化学药品 | 注射剂 | 3/31/2021 | |
| Gabexate Mesylate for Injection | 国药准字H20058489 | 化学药品 | 注射剂 | 10/22/2020 | |
| Gabexate Mesylate for Injection | 国药准字H20093288 | 化学药品 | 注射剂 | 1/8/2020 | |
| Gabexate Mesylate for Injection | 国药准字H20066191 | 化学药品 | 注射剂(注射用无菌粉末) | 11/10/2020 | |
| Gabexate Mesylate for Injection | 国药准字H20084323 | 化学药品 | 注射剂 | 12/7/2022 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||